Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genome-Based Drug Target Identification in Human Pathogen Streptococcus gallolyticus

25 Mar 2021

Abstract excerpt

Streptococcus gallolysticus (Sg) is an opportunistic Gram-positive, non-motile bacterium, which causes infective endocarditis, an inflammation of the inner lining of the heart. As Sg has acquired resistance with the available antibiotics, therefore, there is a dire need to find new therapeutic targets and potent drugs to prevent and treat this disease. In the current study, an in silico approach is utilized to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antimicrobial Resistance in Staphylococcus
Share to Infective Endocarditis Diagnosis and Management
Share to Streptococcal Infections and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33841489
DOI: 10.3389/fgene.2021.564056

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genome-Based Drug Target Identification in Human Pathogen Streptococcus gallolyticusPMID 33841489Read ↗

Identification of New Drug Target in Staphylococcus lugdunensis by Subtractive Genomics Analysis and Their Inhibitors through Molecular Docking and Molecular Dynamic Simulation StudiesSemantic proximity Read ↗

An integrative in-silico approach for therapeutic target identification in the human pathogen Corynebacterium diphtheriaeSemantic proximity Read ↗

Comparative analysis of 31 Streptococcus gallolyticus strains uncovers their potential risks from the perspectives of virulence factors and antibiotic resistance genesSemantic proximity Read ↗

Subtractive Genome Analysis for Identification and Characterization of Novel Drug Targets in the Streptococcus pneumoniae by Using In-silico ApproachSemantic proximity Read ↗

Bridging Drug Discovery through Hierarchical Subtractive Genomics against Asd, Trpg and Secy of Pneumonia Causing MDR Staphylococcus aureusSemantic proximity Read ↗

Computational Study for the Identification of Novel Therapeutic Targets in Haemophilus influenzae by Subtractive Genomics ApproachSemantic proximity Read ↗

Harnessing subtractive genomics for drug target identification in <i>Streptococcus agalactiae</i> serotype v (atcc baa-611 / 2603 v/r) strain: An <i>in-silico</i> approachSemantic proximity Read ↗

In Silico Core Proteomics and Molecular Docking Approaches for the Identification of Novel Inhibitors against Streptococcus pyogenesSemantic proximity Read ↗

Exploring and targeting potential druggable antimicrobial resistance targets ArgS, SecY and MurA in Staphylococcus sciuri with TCM inhibitors through subtractive genomics strategySemantic proximity Read ↗

In Silico Identification of Common Putative Drug Targets among the Pathogens of Bacterial MeningitisSemantic proximity Read ↗

Integrated Bioinformatics-Based Subtractive Genomics Approach to Decipher the Therapeutic Drug Target and Its Possible Intervention against BrucellosisSemantic proximity Read ↗

In Silico Subtractive Proteomics and Molecular Docking Approaches for the Identification of Novel Inhibitors against Streptococcus pneumoniae Strain D39Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.